In8bio logo

In8bio Share Price Today

(NASDAQ: INAB)

In8bio share price is $0.27 & ₹23.48 as on 6 Mar 2025, 2.30 'hrs' IST

$0.27

0.01

(3.51%)

Market is closed - opens 8 PM, 06 Mar 2025

View live In8bio share price in Dollar and Rupees. Guide to invest in In8bio stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in In8bio, along with analyst recommendations, forecasts, and comprehensive financials.

In8bio share price movements

  • Today's Low: $0.25
    Today's High: $0.27

    Day's Volatility :10.41%

  • 52 Weeks Low: $0.22
    52 Weeks High: $1.74

    52 Weeks Volatility :87.53%

In8bio (INAB) Returns

PeriodIn8bio, IncIndex (Russel 2000)
3 Months
-13.7%
0.0%
6 Months
-23.38%
0.0%
1 Year
-77.49%
0.0%
3 Years
-88.98%
-11.6%

In8bio (INAB) Key Statistics

in dollars & INR

Previous Close
$0.2589
Open
$0.249
Today's High
$0.2747
Today's Low
$0.2461
Market Capitalization
$18.8M
Today's Volume
$354.5K
52 Week High
$1.74
52 Week Low
$0.217
Revenue TTM
$0.0
EBITDA
$-29.5M
Earnings Per Share (EPS)
$-0.76
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-241.97%

How to invest in In8bio Stock (INAB) from India?

It is very easy for Indian residents to invest directly in In8bio from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the In8bio stock in both Indian Rupees (INR) and US Dollars (USD). Search for In8bio or INAB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of In8bio or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of In8bio shares which would translate to 3.221 fractional shares of In8bio as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like In8bio, in just a few clicks!

Returns in In8bio (INAB) for Indian investors in Rupees

The In8bio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

In8bio investment value today

Current value as on today

₹28,441

Returns

₹71,559

(-71.56%)

Returns from In8bio Stock

₹76,522 (-76.52%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards In8bio (INAB)

175.0%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Investment in In8bio Shares from India has grown by 175.0% over the past 30 days, indicating increased transactional activity.

147%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for In8bio Stock from India on INDmoney has increased by 147% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in In8bio

  • BIOS CAPITAL MANAGEMENT, LP

    11.86%

  • AIGH Capital Management, LLC

    8.54%

  • Franklin Resources Inc

    7.86%

  • Alyeska Investment Group, L.P.

    6.99%

  • Vanguard Group Inc

    1.96%

  • Sigma Planning Corp

    1.44%

Analyst Recommendation on In8bio

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for In8bio(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on In8bio Stock (INAB)

What analysts predicted

Upside of 1396.3%

Target:

$4.04

Current:

$0.27

Insights on In8bio Stock (Ticker Symbol: INAB)

  • Price Movement

    In the last 1 year, INAB stock has moved down by -79.1%
  • INAB vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 141.4%

In8bio Technicals Summary

Sell

Neutral

Buy

In8bio is currently in a neutral trading position according to technical analysis indicators.

In8bio (INAB) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
In8bio, Inc logo
3.15%
-23.38%
-77.49%
-88.98%
-88.98%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
In8bio, Inc logo
NA
NA
NA
-0.57
-2.42
-0.93
NA
0.18
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
In8bio, Inc logo
Buy
$18.8M
-88.98%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About In8bio

IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of solid and liquid tumors. Its lead product candidates include INB-400, which is in Phase 2 clinical trial to treat newly diagnosed glioblastoma (GBM); INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of GBM and other cancers; and INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with hematologic malignancies undergoing hematopoietic stem cell transplantation. The company develops INB-300 and INB-500 that are in preclinical phase for treatment of acute myeloid leukemia, and other solid and hematological tumor types. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020. IN8bio, Inc. was incorporated in 2016 and is based in New York, New York.
Organization
In8bio
Employees
18
CEO
Mr. Tai-Wei Ho
Industry
Health Technology

Management People of In8bio

NameTitle
Mr. Tai-Wei Ho
Co-Founder, President, CEO & Director
Mr. Patrick McCall CPA
CFO & Secretary
Dr. Lawrence S. Lamb Ph.D.
Executive VP, Co-Founder & Chief Scientific Officer
Dr. Kate Rochlin Ph.D.
Chief Operating Officer

Important FAQs about investing in INAB Stock from India :

What is In8bio share price today?

In8bio share price today stands at $0.27, Open: $0.25 ; Previous Close: $0.26 ; High: $0.27 ; Low: $0.25 ; 52 Week High: $1.74 ; 52 Week Low: $0.22.

The stock opens at $0.25, after a previous close of $0.26. The stock reached a daily high of $0.27 and a low of $0.25, with a 52-week high of $1.74 and a 52-week low of $0.22.

Can Indians buy In8bio shares?

Yes, Indians can invest in the In8bio (INAB) from India.

With INDmoney, you can buy In8bio at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy In8bio at zero transaction cost.

How can I buy In8bio shares from India?

It is very easy to buy In8bio from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of In8bio (INAB) be purchased?

Yes, you can buy fractional shares of In8bio with INDmoney app.

What are the documents required to start investing in In8bio stocks?

To start investing in In8bio, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of In8bio Stock (INAB)?

Today’s highest price of In8bio (INAB) is $0.27.

Today’s lowest price of In8bio (INAB) is $0.25.

What is today's market capitalisation of In8bio?

Today's market capitalisation of In8bio INAB is 18.8M

What is the 52 Week High and Low Range of In8bio Stock (INAB)?

  • 52 Week High

    $1.74

  • 52 Week Low

    $0.22

What are the historical returns of In8bio (INAB)?

  • 1 Month Returns

    3.15%

  • 3 Months Returns

    -23.38%

  • 1 Year Returns

    -77.49%

  • 5 Years Returns

    -88.98%

Who is the Chief Executive Officer (CEO) of In8bio ?

Mr. Tai-Wei Ho is the current Chief Executive Officer (CEO) of In8bio.